Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Acarix

0.27 SEK

+4.03 %

Less than 1K followers

ACARIX

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.03 %
+8.40 %
+1.12 %
-12.30 %
-5.57 %
+28.13 %
-48.86 %
-72.10 %
-96.33 %

Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary artery disease. The company's product is a non-invasive test that is applied with a patch to the patient to analyze sounds from the heart. The business is conducted primarily within the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The headquarters are located in Malmö.

Read more
Market cap
336.19M SEK
Turnover
565.43K SEK
Revenue
7.36M
EBIT %
-652.31 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
7.5
2026

Interim report Q1'26

13.5
2026

General meeting '26

13.8
2026

Interim report Q2'26

All
Press releases
ShowingAll content types
Press release2/13/2026, 12:05 PM

Redeye: Acarix (Q4 review): A solid end to 2025

Acarix
Regulatory press release2/12/2026, 7:00 AM

Acarix Publishes Year-End Report 2025

Acarix
Press release2/11/2026, 8:20 AM

Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System

Acarix

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/4/2026, 8:20 AM

Acarix Receives EU MDR Certification for the CADScor®System

Acarix
Regulatory press release12/8/2025, 7:47 AM

ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION

Acarix
Press release11/6/2025, 7:45 AM

Invitation to presentation of Acarix´s third quarter 2025 report

Acarix
Regulatory press release11/6/2025, 7:00 AM

Acarix Publishes Interim Report, Third quarter 2025

Acarix
Regulatory press release10/27/2025, 2:35 PM

Announcement from the general meeting in Acarix AB

Acarix
Regulatory press release10/24/2025, 1:15 PM

Acarix AB changes Certified Adviser to Tapper Partners AB

Acarix
Press release10/17/2025, 6:30 AM

Acarix responds to G-BA decision on reimbursement in the German market

Acarix
Regulatory press release10/9/2025, 10:15 AM

NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACARIX AB

Acarix
Press release10/7/2025, 7:31 AM

Acarix CADScor® System Gains HealthChoice Reimbursement Coverage

Acarix
Press release9/18/2025, 3:04 PM

Acarix Chairman Jan Poulsen Acquires Shares

Acarix
Press release9/8/2025, 7:45 AM

CEO purchases shares in Acarix

Acarix
Press release8/25/2025, 9:19 AM

Redeye: Acarix Q2 - An eventful quarter

Acarix
Press release8/21/2025, 6:30 AM

Acarix Reports Significant Progress Toward Fixed Reimbursement

Acarix
Regulatory press release8/21/2025, 6:00 AM

Acarix Publishes Interim Report, January – June 2025

Acarix
Press release8/20/2025, 7:45 AM

Acarix and Aalborg University Abstract Accepted for AHA 2025

Acarix
Press release8/18/2025, 9:09 AM

Invitation to presentation of Acarix´s second quarter 2025 report

Acarix
Press release7/28/2025, 7:47 AM

Acarix achieves new Fixed U.S. reimbursement milestone for CADScor at $300.00 USD

Acarix
Forum discussions
On my journey in search of a new Revenio, in a country where vague Finland-Swedish was spoken and which was ruled by Carl XVI Gustaf, I came across a company called Acarix. And I’m not comparing this to be a new Revenio. For the diagnosis of coronary artery disease, a common basic...
9/8/2021, 5:11 AM
by Fisu
9
Odotettu 79 MSEK osakeanti nyt käynnissä: acarix.com Acarix | CADScor®System
12/6/2021, 12:06 AM
by Pohjolan Eka
3
Tärkeimmät talousuutiset | Kauppalehti Acarix CADScor®System included in NICE guidelines (UK) Tärkeimmät ajankohtaiset talousuutiset, pörssikurssit ja kattavat sijoittajapalvelut löydät Kauppalehdestä. Tuossa hieman vanhempaa tiedotetta. Mielenkiintoinen tuote, joka on tutkimuksissa...
9/8/2021, 7:32 AM
by PP2020
3
Mielenkiintoista, että analyytikkofirma on myös neuvonantajana… Onkohan sijoittajana myös.?
9/8/2021, 5:33 AM
by Yoda
3
Redeye:n sivuilta kyllä ko. Yhtiön kohdalta löytyy Disclosures joka kertoo omistaako Redeye yhtiötä. Tässä tapauksessa ei omista. redeye.se Acarix Disclosures - Redeye Discover the latest equity research on Acarix.
9/8/2021, 2:45 PM
by Llopardi
2
PubMed Economic Analysis of the CADScor System for Ruling Out Coronary Artery... The CADScor System is a potentially cost-saving test for the diagnosis of CAD. When initiated before the use of non-invasive cardiac imaging tests such as computed tomography coronary angiography, the...
9/8/2021, 5:40 AM
by PP2020
2
Uutista Amerikan mailta on tullut, en osaa sitä tänne siirtää. Kiitos jo etukäteen
10/27/2021, 11:02 AM
by Hollitupa
1
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.